Long-term implications of bone loss in breast cancer
- 31 December 2004
- journal article
- review article
- Published by Elsevier in The Breast
- Vol. 13 (1) , 29-37
- https://doi.org/10.1016/j.breast.2004.09.005
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Aging Bone and OsteoporosisArchives of internal medicine (1960), 2003
- Current and future status of adjuvant therapy for breast cancerCancer, 2003
- Goserelin Versus Cyclophosphamide, Methotrexate, and Fluorouracil as Adjuvant Therapy in Premenopausal Patients With Node-Positive Breast Cancer: The Zoladex Early Breast Cancer Research Association StudyJournal of Clinical Oncology, 2002
- Intravenous Zoledronic Acid in Postmenopausal Women with Low Bone Mineral DensityNew England Journal of Medicine, 2002
- Dual Energy X-Ray Absorptiometry and Its Clinical ApplicationsSeminars in Musculoskeletal Radiology, 2002
- Osteoporosis Due to Cancer Treatment: Pathogenesis and ManagementJournal of Clinical Oncology, 2000
- Mortality after all major types of osteoporotic fracture in men and women: an observational studyThe Lancet, 1999
- Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients.Journal of Clinical Oncology, 1997
- Bone Marrow, Cytokines, and Bone Remodeling — Emerging Insights into the Pathophysiology of OsteoporosisNew England Journal of Medicine, 1995
- Bone mineral density after adjuvant chemotherapy for premenopausal breast cancerBritish Journal of Cancer, 1990